Registry to study factors that may impact COVID-19 occurrence and severity (CARE)

Study identification

• EU PAS number:
  EUPAS36240
• Study ID:
  45755
• Official title and acronym:
  Registry to study factors that may impact COVID-19 occurrence and severity (CARE)
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom

  United States
• Study description:
  This is an observational, direct-to-participant, web-based, longitudinal study of adults with potential exposure to COVID-19 to better understand risk factors, symptoms, and treatments for COVID-19 illness.
• Study status:
  Ongoing

Research institutions and networks

Institutions

IQVIA

United Kingdom

Study timelines

Date when funding contract was signed

Planned: 01/04/2020

Actual: 01/04/2020

Study start date

Planned: 22/04/2020

Actual: 22/04/2020

Data analysis start date

Planned: 28/04/2020

Actual: 28/04/2020

Date of final study report

Planned: 14/01/2022

Sources of funding

Pharmaceutical company and other private sector 

Other

More details on funding

Pfizer, FDA, IQVIA

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

Participants enter information here:,https://www.helpstopcovid19.com/